Henry Wheeler Center for Emerging and Neglected Diseases

The mission of the Henry Wheeler Center for Emerging & Neglected Diseases (CEND) is to help the University of California, Berkeley make innovative and substantial contributions to the global response to emerging and neglected infectious diseases. CEND believes that by educating potential innovators, connecting researchers from diverse disciplines, and investing in research, they can help the best and brightest minds at UC Berkeley access the resources they need to make meaningful and innovative contributions to our scientific understanding and ability to combat emerging and neglected diseases.

Director
Jeff Cox
Email
jeff.cox@berkeley.edu
Telephone
(510) 664-7206
Staff contact
Julia Schaletzky (Executive Director)
Email
jschaletzky@berkeley.edu
Mailing address

Center for Emerging & Neglected Diseases University of California, Berkeley 344A Li Ka Shing Center Berkeley, CA 94720-3370



In News

February 5, 2021

Can hepatitis C drugs help remdesivir fight COVID-19?

Since the coronavirus pandemic began, only one antiviral drug, remdesivir, has been approved in the United States for treatment of COVID-19, but it barely works and is toxic to the liver. Researchers at UC Berkeley have found 20 compounds that, in combination with remdesivir, are much better than remdesivir alone in protecting human lung cells from SARS-CoV-2, the virus that causes COVID-19.